Showing results (421-430 of 1,103) with videos related to
Sort By:
Pageof 111
Current Gene Therapy|September 8, 2025
Advances in Gene Therapy Clinical Trials for Hemophilia CareAmita Joshi Rana, Md Sadique Hussain, Vikas Jakhmola, et al.Current Gene Therapy|October 17, 2025
5-Alpha Reductase Deficiency - An Uncommon Disorder of Sexual Development: A Case Study of Four Turkish Patients within a FamilyAli Örs, Muhammed Burak Bereketoğlu, Asli Boz, et al.Current Gene Therapy|July 30, 2025
DrugSurvPlot: A Novel Web-Based Platform Harnessing Drug Sensitivity Scores as Molecular Biomarkers for Pan-Cancer Survival PrognosisYing Shi, Qirui Shen, Aimin Jiang, et al.Current Gene Therapy|July 30, 2025
Association of KIM-1 (HAVCR1) Expression with the Tumor Immune Microenvironment in Clear Cell Renal Cell CarcinomaPanagiotis J Vlachostergios, Athanasios Karathanasis, Foteini Karasavvidou, et al.Current Gene Therapy|July 30, 2025
Pathogens Association with Alzheimer Disease: Emerging Concepts and New PerspectivesUma Agarwal, Rajiv Kumar Tonk, Saroj VermaCurrent Gene Therapy|July 22, 2014
Intracellular delivery of potential therapeutic genes: prospects in cancer gene therapyAthirah Bakhtiar, Mustak Sayyad, Rozita Rosli, et al.Current Gene Therapy|July 22, 2014
Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapyZhenzhen Yang, Bai Xiang, Dawen Dong, et al.Current Gene Therapy|April 18, 2013
Prevalence of neutralizing factors against adeno-associated virus types 2 in age-related macular degeneration and polypoidal choroidal vasculopathyYong Cheng, Lvzhen Huang, Xiaoxin Li, et al.Current Gene Therapy|March 1, 2013
Modelling human disease with pluripotent stem cellsRichard Siller, Sebastian Greenhough, In-Hyun Park, et al.Current Gene Therapy|January 16, 2013
Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone productionBarbara Lombardo, Teresa Rocco, Maria T Esposito, et al.Pageof 111